Dividend-News

Daily dividend news for investors in dividend stocks


Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2019 Results - Earnings Call Transcript

Published Mon, 12 Aug 2019 22:21:18 -0400 on Seeking Alpha

Yield10 Bioscience, Inc. (Nasdaq: YTEN) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET
Company Participants
Lynne Brum - VP of Planning and Corporate Communications
Oliver Peoples - President and CEO
Kristi Snell - VP of Research and CSO
Conference Call Participants
Jon Hickman - Ladenburg Thalmann
Ben Klieve - National Securities
Operator
Welcome to the Second Quarter 2019 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen only mode. The presenters will address questions from analysts today. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference call over to your host, Yield10 Vice President of Planning and Corporate Communications, Lynne Brum.
Lynne Brum
Thank you, Diego, and good afternoon, everyone. Welcome to Yield10 Bioscience second quarter 2019 conference call.
Joining me on the call today are President and CEO, Dr. Oliver Peoples; Vice President of Research and Chief Science Officer, Dr. Kristi Snell; and Chief Accounting Officer, Chuck Haaser. Earlier this afternoon, Yield10 released our second quarter 2019 financial results. This release as well as slides to accompany our presentation today are available on the Investor Relations event section of our website at yield10bio.com.
Let's turn to slide two. Please note as part of our discussion today, management will be... Read more